英国新增4例新型冠状病毒感染病例,目前感染总计8人

2020-02-11 不详 MedSci原创

英国新增四例新型冠状病毒(2019-nCoV)感染病例,内政大臣普里蒂·帕特尔(Priti Patel)宣布疫情是"对公共健康的严重且迫在眉睫的威胁",目前英国感染人数总计8人。

英国新增四例新型冠状病毒(2019-nCoV)感染病例,内政大臣普里蒂·帕特尔(Priti Patel)宣布疫情是"对公共健康的严重且迫在眉睫的威胁",目前英国感染人数总计8人。

尽管内政大臣宣布疫情为"严重而迫在眉睫的威胁",但英国公共卫生部宣布的官方威胁级别仍然适中。根据新宣布的措施,政府现在能够强行隔离对公共健康构成威胁的人。

随着冠状病毒继续对全球公共卫生构成威胁,公共卫生组织,政府机构和药物开发商已经行动起来,包括美国食品药品监督管理局(FDA),该组织表示将授权疾病控制和预防中心(CDC)的2019-nCov诊断小组,以检测"符合2019-nCov冠状病毒感染病例"。

欧洲药品管理局(EMA)也宣布将通过所有可用的监管工具支持药物开发人员,以促进该病毒的药物和疫苗的开发。

与此同时在中国,将启动多达十二项临床试验。

在世界卫生组织(WHO)也已表示,将加快研究冠状病毒,并将于2月11-12日在日内瓦举行论坛,以"汇集领先的科学家和公共卫生机构,卫生部和研究资助者",致力于新型冠状病毒的"疫苗,治疗药物和诊断的研究与开发"。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1840217, encodeId=b9c6184021ed8, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Thu Nov 12 08:03:00 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636194, encodeId=d36b16361942a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Sep 11 07:03:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379176, encodeId=061f3e917669, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:26 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379175, encodeId=4e233e91759d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:14 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604335, encodeId=5acd1604335c8, content=<a href='/topic/show?id=71b95335396' target=_blank style='color:#2F92EE;'>#感染病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53353, encryptionId=71b95335396, topicName=感染病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=337119178396, createdName=xugc, createdTime=Thu Feb 13 01:03:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1840217, encodeId=b9c6184021ed8, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Thu Nov 12 08:03:00 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636194, encodeId=d36b16361942a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Sep 11 07:03:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379176, encodeId=061f3e917669, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:26 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379175, encodeId=4e233e91759d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:14 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604335, encodeId=5acd1604335c8, content=<a href='/topic/show?id=71b95335396' target=_blank style='color:#2F92EE;'>#感染病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53353, encryptionId=71b95335396, topicName=感染病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=337119178396, createdName=xugc, createdTime=Thu Feb 13 01:03:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1840217, encodeId=b9c6184021ed8, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Thu Nov 12 08:03:00 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636194, encodeId=d36b16361942a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Sep 11 07:03:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379176, encodeId=061f3e917669, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:26 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379175, encodeId=4e233e91759d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:14 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604335, encodeId=5acd1604335c8, content=<a href='/topic/show?id=71b95335396' target=_blank style='color:#2F92EE;'>#感染病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53353, encryptionId=71b95335396, topicName=感染病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=337119178396, createdName=xugc, createdTime=Thu Feb 13 01:03:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2020-02-13 thm112988

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1840217, encodeId=b9c6184021ed8, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Thu Nov 12 08:03:00 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636194, encodeId=d36b16361942a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Sep 11 07:03:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379176, encodeId=061f3e917669, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:26 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379175, encodeId=4e233e91759d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:14 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604335, encodeId=5acd1604335c8, content=<a href='/topic/show?id=71b95335396' target=_blank style='color:#2F92EE;'>#感染病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53353, encryptionId=71b95335396, topicName=感染病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=337119178396, createdName=xugc, createdTime=Thu Feb 13 01:03:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2020-02-13 thm112988

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1840217, encodeId=b9c6184021ed8, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Thu Nov 12 08:03:00 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636194, encodeId=d36b16361942a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Sep 11 07:03:00 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379176, encodeId=061f3e917669, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:26 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379175, encodeId=4e233e91759d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Thu Feb 13 07:56:14 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604335, encodeId=5acd1604335c8, content=<a href='/topic/show?id=71b95335396' target=_blank style='color:#2F92EE;'>#感染病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53353, encryptionId=71b95335396, topicName=感染病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=337119178396, createdName=xugc, createdTime=Thu Feb 13 01:03:00 CST 2020, time=2020-02-13, status=1, ipAttribution=)]
    2020-02-13 xugc

相关资讯

英国研究人员发现可防止肥胖的基因变体

遗传因素会影响人的胖瘦早已为人所知。日前,英国剑桥大学研究人员宣布他们发现了可以防止肥胖的基因变体,可为开发治疗肥胖症新药提供思路。

英国授权开展全球针对肾脏移植免疫排斥反应的CAR-Treg细胞疗法临床研究

英国药品保健产品监管局(MHRA)已授权Sangamo Therapeutics开展首个嵌合抗原受体调节性T细胞(CAR-Treg)疗法TX200的临床试验STEADFAST。TX200正在研究用于预防HLA-A2错配肾脏移植治疗终末期肾脏疾病(ESRD)后免疫介导的排斥反应。

英国确认首例新型冠状病毒感染病例引起全球关注

在世界卫生组织(WHO)前天宣布爆发全球紧急事件之后,英国昨天早上确认了头两例新型冠状病毒感染病例。

英国将为男孩免费接种HPV疫苗

英国政府9日宣布,从今年9月起,人乳头瘤病毒(HPV)疫苗接种计划覆盖范围将从女孩扩展至男孩,估计未来40年将避免数万例癌症病例发生。HPV疫苗又称宫颈癌疫苗,可通过阻止HPV感染预防相关癌症发生,包括宫颈癌、阴茎癌、肛门癌、某些头颈癌等。英格兰公共卫生局当天发布公报说,据英国沃里克大学建立的模型估算,到2058年,也就是英国启动HPV疫苗接种计划50年时,该疫苗将在英国可能阻止超过6.4万例宫颈

为准备脱欧,英国提供紧急医疗服务

英国卫生和社会关怀部宣布将签订2500万英镑合同的快递货运服务,以提供紧急药品和医疗产品,作为脱欧准备工作的一部分。

英国将领导价值2亿英镑的50万人的全基因组测序

英国研究与创新中心宣布了一项新的价值2亿英镑项目,对50万人的遗传密码进行测序,以更好地理解,诊断,治疗和预防改变生命的疾病,包括癌症和痴呆症。